IL155400A0 - Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof - Google Patents

Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof

Info

Publication number
IL155400A0
IL155400A0 IL15540001A IL15540001A IL155400A0 IL 155400 A0 IL155400 A0 IL 155400A0 IL 15540001 A IL15540001 A IL 15540001A IL 15540001 A IL15540001 A IL 15540001A IL 155400 A0 IL155400 A0 IL 155400A0
Authority
IL
Israel
Prior art keywords
venlafaxine
preparing
processes
crystalline
base
Prior art date
Application number
IL15540001A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL155400(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL155400A0 publication Critical patent/IL155400A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15540001A 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof IL155400A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21
PCT/US2001/051017 WO2002045658A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (1)

Publication Number Publication Date
IL155400A0 true IL155400A0 (en) 2003-11-23

Family

ID=27500045

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15540001A IL155400A0 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
IL196287A IL196287A0 (en) 2000-10-19 2008-12-31 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL196287A IL196287A0 (en) 2000-10-19 2008-12-31 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof

Country Status (20)

Country Link
US (1) US20020143211A1 (xx)
EP (1) EP1334082A4 (xx)
JP (2) JP2004530638A (xx)
KR (1) KR20030059206A (xx)
CN (1) CN1620420A (xx)
AU (1) AU2002241764A1 (xx)
CA (1) CA2426158A1 (xx)
CZ (1) CZ20031298A3 (xx)
DE (1) DE01988460T1 (xx)
ES (1) ES2206082T1 (xx)
HR (1) HRP20030392A2 (xx)
HU (1) HUP0303496A3 (xx)
IL (2) IL155400A0 (xx)
IS (1) IS6789A (xx)
MX (1) MXPA03003459A (xx)
NO (1) NO20031743L (xx)
PL (1) PL365895A1 (xx)
SK (1) SK5762003A3 (xx)
WO (1) WO2002045658A2 (xx)
YU (1) YU30203A (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en) 2000-10-31 2006-12-14 Sandoz Ag Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
EP1451145A1 (en) 2001-12-05 2004-09-01 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
EP1487429A2 (en) * 2002-03-28 2004-12-22 Synthon B.V. Compositions of venlafaxine base
AU2003226751A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
EP1485344A1 (en) 2002-03-28 2004-12-15 Synthon B.V. Venlafaxine besylate
DE10359154A1 (de) * 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
EP1806335A4 (en) * 2004-10-20 2008-12-03 Mitsubishi Tanabe Pharma Corp METHOD FOR PRODUCING A PHENYLETHANOLAMINE COMPOUND AND INTERMEDIATE PRODUCTS THEREFOR
KR20080056311A (ko) * 2005-10-19 2008-06-20 테바 파마슈티컬 인더스트리즈 리미티드 고순도1-[2-디메틸아미노-(4-메톡시페닐)에틸)시클로헥산올염산염의 제조 방법
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
EP2032521B1 (en) 2006-06-27 2009-10-28 Sandoz AG New method for salt preparation
WO2008038146A2 (en) * 2006-07-14 2008-04-03 Medichem, S.A. Improved processes for preparing vanlafaxine base and salts thereof
RU2576665C2 (ru) * 2010-10-01 2016-03-10 Йоуксин ЛИ Полиморфы 4-[2-диметиламино-1-(1-гидроксициклогексил)этил]фенил 4-метилбензоата гидрохлорида, способы их получения и использование
CR20200220A (es) 2013-11-15 2020-11-18 Akebia Therapeutics Inc FORMAS SÓLIDAS DE ÁCIDO {[5-(3-CLOROFENIL)-3-HIDROXIPIRIDIN-2-CARBONIL]AMINO}ACÉTICO, COMPOSICIONES, Y USOS DE LAS MISMAS (Divisional 2016-0222)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (xx) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en) 2000-10-31 2006-12-14 Sandoz Ag Crystalline forms of venlafaxine hydrochloride
AU2001235970A1 (en) 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
ES2206082T1 (es) 2004-05-16
JP2008239629A (ja) 2008-10-09
KR20030059206A (ko) 2003-07-07
WO2002045658A2 (en) 2002-06-13
DE01988460T1 (de) 2004-04-22
IS6789A (is) 2003-04-15
AU2002241764A1 (en) 2002-06-18
WO2002045658A3 (en) 2003-01-16
CA2426158A1 (en) 2002-06-13
YU30203A (sh) 2006-08-17
HUP0303496A2 (hu) 2004-01-28
EP1334082A2 (en) 2003-08-13
IL196287A0 (en) 2011-08-01
HUP0303496A3 (en) 2005-08-29
PL365895A1 (en) 2005-01-10
JP2004530638A (ja) 2004-10-07
SK5762003A3 (en) 2003-11-04
NO20031743L (no) 2003-06-18
CN1620420A (zh) 2005-05-25
US20020143211A1 (en) 2002-10-03
HRP20030392A2 (en) 2005-04-30
EP1334082A4 (en) 2006-02-01
NO20031743D0 (no) 2003-04-15
CZ20031298A3 (cs) 2003-10-15
MXPA03003459A (es) 2005-04-29

Similar Documents

Publication Publication Date Title
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
EP1463711A4 (en) "NEW POLYMORPH OF SERTRALINE HYDROCHLORIDE AND COMPOSITION CONTAINING THEREOF, NEW METHODS OF PREPARING SERTRALINE HYDROCHLORIDE POLYMORPHES AND AMORPH FORM"
IL149050A0 (en) Polymorphic forms of sertraline hydrochloride
HK1067123A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
IL162171A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1289928A4 (en) NEW AMORPHOUS FORM OF SERTRALINE HYDROCHLORIDE
HUP0400299A2 (en) Polymorphs of fexofenadine hydrochloride
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
IL159266A (en) Crystalline forms of fexofenadine and processes for the preparation thereof
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
PL2181982T3 (pl) Sposób wytwarzania chlorowodorku wenlafaksyny w formie I
AU2003297640A8 (en) Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
HUP0302144A3 (en) Process of preparation of aliphatic amines
PL372137A1 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
PL376832A1 (pl) Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny
AU2003243153A8 (en) Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2002308095A1 (en) Process for preparing sertraline hydrochloride polymorphic form ii
IL161816A0 (en) Polymorphs of fexofenadine base
IL140632A0 (en) A novel process for the preparation of paroxetine and novel intermediates thereof